InvestorsHub Logo
icon url

DewDiligence

10/29/12 7:57 AM

#151411 RE: biotech_researcher #151410

Currently, essentially all treatment for CML is chronic. The question is whether this lucrative business will change if one or more of the TKI's allow patients with a complete response to stop treatment.